Analysis

Pharma Technology Focus – Issue 50

Pharma Technology Focus – Issue 50

June's top stories: Bayer reported positive results of RESORCE trial, TapImmune initiated Phase II trial of TPIV 200

June's top stories: Bayer reported positive results of RESORCE trial, TapImmune initiated Phase II trial of TPIV 200

May's top stories: ProMedica began human stem cell trial, Cerulean dosed in Phase l/ll combination trial

May's top stories: ProMedica began human stem cell trial, Cerulean dosed in Phase l/ll combination trial

April's top stories: SynbiCITE's synthetic biology foundry, Omeros's phase II clinical trial of OMS721

April's top stories: SynbiCITE's synthetic biology foundry, Omeros's phase II clinical trial of OMS721

March's top stories: Tracon's Phase IbTRC105 clinical trial, ADC begins ADCT-402 trial

March's top stories: Tracon's Phase IbTRC105 clinical trial, ADC begins ADCT-402 trial

Pharma Technology Focus – Issue 45

Pharma Technology Focus – Issue 45

February's top stories: 60% of trial results not shared, Dilaforette-AGU team-up

February's top stories: 60% of trial results not shared, Dilaforette-AGU team-up

Pharma Technology Focus - Issue 44

Pharma Technology Focus - Issue 44

January's top stories: Profectus Ebola trial, AstraZeneca-Incyte lung cancer drug

January's top stories: Profectus Ebola trial, AstraZeneca-Incyte lung cancer drug

Pharma Technology Focus – Issue 43

Pharma Technology Focus – Issue 43

2015: The year's biggest Drug Development Technology stories

2015: The year's biggest Drug Development Technology stories

November's top stories: Phase III trial of sirukumab, Lyrica fails trial

November's top stories: Phase III trial of sirukumab, Lyrica fails trial

Pharma Technology Focus – Issue 42

Pharma Technology Focus – Issue 42

Pharma Technology Focus - Issue 41

Pharma Technology Focus - Issue 41

October's top stories: New cancer drug delivery approach, J&J Ebola trial

October's top stories: New cancer drug delivery approach, J&J Ebola trial

Pharma Technology Focus - Issue 40

Pharma Technology Focus - Issue 40

September's top stories: GSK-Theravance COPD study, AstraZeneca cUTI results

September's top stories: GSK-Theravance COPD study, AstraZeneca cUTI results

August's top stories: Pfizer’s cancer trial, Jardiance diabetes study results

August's top stories: Pfizer’s cancer trial, Jardiance diabetes study results

July's top stories: Novavax Ebola trial, Nestlé pregnancy nutrients study

July's top stories: Novavax Ebola trial, Nestlé pregnancy nutrients study

June's top stories: Pfizer’s Phase III study in SCD, Korea begins MERS trial

June's top stories: Pfizer’s Phase III study in SCD, Korea begins MERS trial

May's top stories: Amgen’s skin cancer trial, Novartis COPD Phase III study

May's top stories: Amgen’s skin cancer trial, Novartis COPD Phase III study
cachename:Featurescachekey:rd-137342983_-144940029_rd-1665407042_727740091_rd-488908060_1460672566_ap1460672566_727740091_-1676084538